• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?

作者信息

Ewer Michael S, Tan-Chiu Elizabeth

出版信息

J Clin Oncol. 2007 Dec 1;25(34):5532-3; author reply 5533-4. doi: 10.1200/JCO.2007.14.0657.

DOI:10.1200/JCO.2007.14.0657
PMID:18048835
Abstract
摘要

相似文献

1
Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?曲妥珠单抗心脏毒性的可逆性：这个概念还存在且适用吗？
J Clin Oncol. 2007 Dec 1;25(34):5532-3; author reply 5533-4. doi: 10.1200/JCO.2007.14.0657.
2
Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be?蒽环类辅助化疗后曲妥珠单抗相关心脏毒性：我们应多担忧？
J Clin Oncol. 2010 Jul 20;28(21):3407-10. doi: 10.1200/JCO.2009.26.0125. Epub 2010 Jun 7.
3
Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.治疗洞察：蒽环类药物与曲妥珠单抗——心脏毒性副作用的最佳管理
Nat Clin Pract Oncol. 2008 Jun;5(6):324-35. doi: 10.1038/ncponc1090. Epub 2008 Mar 25.
4
Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.乳腺癌患者的蒽环类药物心脏毒性：与曲妥珠单抗和紫杉类药物的协同作用。
Cardiovasc Toxicol. 2007;7(2):67-71. doi: 10.1007/s12012-007-0013-5.
5
Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility.曲妥珠单抗相关的心脏毒性：对可逆性概念提出质疑。
J Clin Oncol. 2007 Aug 10;25(23):3525-33. doi: 10.1200/JCO.2007.11.0106.
6
Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary?HER2阳性乳腺癌的辅助治疗：蒽环类药物仍然有必要使用吗？
Clin Adv Hematol Oncol. 2008 Sep;6(9):666-72.
7
Anthracyclines and trastuzumab; getting to the heart of the matter: when getting to the heart is the matter.蒽环类药物和曲妥珠单抗；触及问题的核心：当心脏成为问题所在时。
Breast Cancer Res Treat. 2011 Jun;127(2):585-6. doi: 10.1007/s10549-008-0172-5. Epub 2008 Sep 13.
8
Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.肌钙蛋白I有助于深入了解心脏毒性以及蒽环类药物与曲妥珠单抗的相互作用。
J Clin Oncol. 2010 Sep 1;28(25):3901-4. doi: 10.1200/JCO.2010.30.6274. Epub 2010 Aug 2.
9
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.乳腺癌患者使用曲妥珠单抗相关的心脏毒性。
Expert Rev Anticancer Ther. 2007 Dec;7(12):1763-71. doi: 10.1586/14737140.7.12.1763.
10
Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?曲妥珠单抗进展后治疗：心脏毒性风险真的不会增加吗？
J Clin Oncol. 2009 Sep 20;27(27):e123; author reply e124-5. doi: 10.1200/JCO.2009.23.9327. Epub 2009 Aug 17.

引用本文的文献

1
Cardiotoxicity in Breast Cancer Therapy: Risks, Mechanisms, and Prevention Strategies.乳腺癌治疗中的心脏毒性：风险、机制及预防策略。
Med Sci (Basel). 2025 Aug 14;13(3):130. doi: 10.3390/medsci13030130.
2
Cardiac toxic effect of radiation therapy in patients receiving adjuvant trastuzumab treatment, as examined by LVEF of echocardiography: an experimental research.通过超声心动图左心室射血分数（LVEF）检测接受辅助曲妥珠单抗治疗患者放疗的心脏毒性作用：一项实验研究
Ann Med Surg (Lond). 2023 Apr 25;85(7):3434-3438. doi: 10.1097/MS9.0000000000000529. eCollection 2023 Jul.
3
Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance.
赫赛汀介导的心脏毒性：通过心血管磁共振成像进行评估。
Cardiol Res Pract. 2022 Feb 27;2022:1910841. doi: 10.1155/2022/1910841. eCollection 2022.
4
Association of Cardiotoxicity With Doxorubicin and Trastuzumab: A Double-Edged Sword in Chemotherapy.多柔比星与曲妥珠单抗导致的心脏毒性：化疗中的双刃剑
Cureus. 2021 Sep 22;13(9):e18194. doi: 10.7759/cureus.18194. eCollection 2021 Sep.
5
Early Cardiotoxicity after Adjuvant Concomitant Treatment with Radiotherapy and Trastuzumab in Patients with Breast Cancer.乳腺癌患者辅助放疗联合曲妥珠单抗治疗后的早期心脏毒性
Radiol Oncol. 2018 Feb 25;52(2):204-212. doi: 10.2478/raon-2018-0011. eCollection 2018 Jun.
6
Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab.左侧乳腺癌辅助放疗联合或不联合曲妥珠单抗后的早期心脏毒性。
Oncotarget. 2016 Jan 5;7(1):1042-54. doi: 10.18632/oncotarget.6053.
7
Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer.早期乳腺癌同步放化疗和曲妥珠单抗的心脏毒性。
Radiol Oncol. 2014 Apr 25;48(2):105-12. doi: 10.2478/raon-2013-0040. eCollection 2014 Jun.
8
Cutaneous and cardiac toxicity of concurrent trastuzumab and adjuvant breast radiotherapy: a single institution series.曲妥珠单抗与辅助性乳腺放疗同时使用时的皮肤和心脏毒性：单机构系列研究
Med Oncol. 2014 Apr;31(4):891. doi: 10.1007/s12032-014-0891-x. Epub 2014 Feb 18.
9
Cardiotoxicity of molecularly targeted agents.分子靶向药物的心脏毒性
Curr Cardiol Rev. 2011 Nov;7(4):221-33. doi: 10.2174/157340311799960636.
10
Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005.1998-2005 年，在一个大型全国范围内的老年乳腺癌女性队列中，蒽环类药物和曲妥珠单抗的使用与心脏风险相关。
Med Oncol. 2011 Dec;28 Suppl 1:S80-90. doi: 10.1007/s12032-010-9717-7. Epub 2010 Oct 22.